These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-κB pathways. Zhou J; Xu G; Ma S; Li F; Yuan M; Xu H; Huang K Biochem Biophys Res Commun; 2015 Nov; 467(4):853-8. PubMed ID: 26474703 [TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Lappas M; Yee K; Permezel M; Rice GE Endocrinology; 2005 Mar; 146(3):1491-7. PubMed ID: 15564333 [TBL] [Abstract][Full Text] [Related]
9. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065 [TBL] [Abstract][Full Text] [Related]
10. Inflammation, cytokines and insulin resistance: a clinical perspective. Wieser V; Moschen AR; Tilg H Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037 [TBL] [Abstract][Full Text] [Related]
11. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944 [TBL] [Abstract][Full Text] [Related]
12. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Oliver E; McGillicuddy F; Phillips C; Toomey S; Roche HM Proc Nutr Soc; 2010 May; 69(2):232-43. PubMed ID: 20158940 [TBL] [Abstract][Full Text] [Related]
13. "Spicing up" of the immune system by curcumin. Jagetia GC; Aggarwal BB J Clin Immunol; 2007 Jan; 27(1):19-35. PubMed ID: 17211725 [TBL] [Abstract][Full Text] [Related]
14. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats. Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547 [TBL] [Abstract][Full Text] [Related]
15. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Araújo EP; De Souza CT; Ueno M; Cintra DE; Bertolo MB; Carvalheira JB; Saad MJ; Velloso LA Endocrinology; 2007 Dec; 148(12):5991-7. PubMed ID: 17761768 [TBL] [Abstract][Full Text] [Related]
16. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. Wu SJ; Tam KW; Tsai YH; Chang CC; Chao JC Am J Chin Med; 2010; 38(1):99-111. PubMed ID: 20128048 [TBL] [Abstract][Full Text] [Related]
17. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes. Ndisang JF; Jadhav A Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386 [TBL] [Abstract][Full Text] [Related]